Delivery Order SPE2DR25D7059-SPE2DR26F7MXK
- Not listed
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.60 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,813.78 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award involved no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,585.12 delivery order (4570221803) to AmerisourceBergen Drug Corp for Act-O-Vials, a pharmaceutical product delivery, with performance in Conshohocken, Pennsylvania and completion by December 10, 2025. This is a firm fixed-price, non-set-aside contract executed on December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order...
- The Defense Logistics Agency awarded a delivery order valued at $18,799.18 to AmerisourceBergen Drug Corp for Act-O-Vials on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MXKDelivery Order
The Defense Logistics Agency awarded a $10,626.56 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on December 15, 2025, with completion expected by December 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds a significant $999,999,999 indefinite delivery contract with DLA Troop Support Medical (SPE2DX) running through December 2026, which provides a comprehensive global pharmaceutical support platform. Through this vehicle and related delivery orders, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical supplies—including specialty medications, vaccines, devices, and medical commodities—to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The current delivery order for Act-O-Vials represents one of numerous small-to-moderate value transactions executed under this broader framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 12/14/25 |